GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (OTCPK:SNANF) » Definitions » Cash Ratio

SNANF (Sona Nanotech) Cash Ratio : 0.02 (As of Jul. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Sona Nanotech's Cash Ratio for the quarter that ended in Jul. 2024 was 0.02.

Sona Nanotech has a Cash Ratio of 0.02. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Sona Nanotech's Cash Ratio or its related term are showing as below:

SNANF' s Cash Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.37   Max: 2.29
Current: 0.02

During the past 13 years, Sona Nanotech's highest Cash Ratio was 2.29. The lowest was 0.02. And the median was 0.37.

SNANF's Cash Ratio is ranked worse than
95.09% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.97 vs SNANF: 0.02

Sona Nanotech Cash Ratio Historical Data

The historical data trend for Sona Nanotech's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Cash Ratio Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.03 0.58 0.39 0.11

Sona Nanotech Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.11 0.19 0.03 0.02

Competitive Comparison of Sona Nanotech's Cash Ratio

For the Diagnostics & Research subindustry, Sona Nanotech's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Cash Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Cash Ratio falls into.



Sona Nanotech Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Sona Nanotech's Cash Ratio for the fiscal year that ended in Oct. 2023 is calculated as:

Cash Ratio (A: Oct. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.084/0.772
=0.11

Sona Nanotech's Cash Ratio for the quarter that ended in Jul. 2024 is calculated as:

Cash Ratio (Q: Jul. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.018/1.118
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sona Nanotech  (OTCPK:SNANF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Sona Nanotech Cash Ratio Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc is engaged in researching and developing gold nanorod products. It makes products for diagnostic tests and medical treatment applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

From GuruFocus